Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Haematologica|April 12, 2012
A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host diseaseMaria Cuzzola, Maurizio Fiasché, Pasquale Iacopino, et al.
Tumori|June 15, 2007
Wernicke's encephalopathy after allogeneic stem cell transplantationGiuseppe Messina, Eugenia Quartarone, Giuseppe Console, et al.
American Journal of Hematology|August 5, 2006
High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patientsMassimo Martino, Giuseppe Console, Giuseppe Irrera, et al.
Expert Opinion on Investigational Drugs|April 5, 2013
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myelomaMassimo Martino, Attilio Olivieri, Massimo Offidani, et al.
Blood Transfusion = Trasfusione Del Sangue|February 17, 2012
The impact of early CD4+ lymphocyte recovery on the outcome of patients who undergo allogeneic bone marrow or peripheral blood stem cell transplantationRoberta Fedele, Massimo Martino, Cristina Garreffa, et al.
British Journal of Haematology|October 22, 2013
Plerixafor on-demand combined with chemotherapy and granulocyte colony-stimulating factor: significant improvement in peripheral blood stem cells mobilization and harvest with no increase in costsGiuseppe Milone, Massimo Martino, Andrea Spadaro, et al.
Haematologica|November 5, 2002
Feasibility of a mixed inpatient-outpatient model of peripheral blood stem cell transplantation for multiple myelomaFortunato Morabito, Massimo Martino, Caterina Stelitano, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 28, 2017
Basal CD34+ Cell Count Predicts Peripheral Blood Stem Cell Mobilization in Healthy Donors after Administration of Granulocyte Colony-Stimulating Factor: A Longitudinal, Prospective, Observational, Single-Center, Cohort StudyMassimo Martino, Mercedes Gori, Annalisa Pitino, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 14, 2004
Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patientsMassimo Martino, Esther Oliva, Giuseppe Console, et al.
Expert Review of Hematology|June 29, 2019
Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trialsMassimo Martino, Marco Rossi, Anna Ferreri, et al.
Pageof 17